Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140404153> ?p ?o ?g. }
- W2140404153 endingPage "183" @default.
- W2140404153 startingPage "175" @default.
- W2140404153 abstract "PurposeTo demonstrate the feasibility of magnetic resonance lymphography (MRL) –guided delineation of a boost volume and an elective target volume for pelvic lymph node irradiation in patients with prostate cancer. The feasibility of irradiating these volumes with a high-dose boost to the MRL-positive lymph nodes in conjunction with irradiation of the prostate using intensity-modulated radiotherapy (IMRT) was also investigated.Methods and MaterialsIn 4 prostate cancer patients with a high risk of lymph node involvement but no enlarged lymph nodes on CT and/or MRI, MRL detected pathological lymph nodes in the pelvis. These lymph nodes were identified and delineated on a radiotherapy planning CT to create a boost volume. Based on the location of the MRL-positive lymph nodes, the standard elective pelvic target volume was individualized. An IMRT plan with a simultaneous integrated boost (SIB) was created with dose prescriptions of 42 Gy to the pelvic target volume, a boost to 60 Gy to the MRL-positive lymph nodes, and 72 Gy to the prostate.ResultsAll MRL-positive lymph nodes could be identified on the planning CT. This information could be used to delineate a boost volume and to individualize the pelvic target volume for elective irradiation. IMRT planning delivered highly acceptable radiotherapy plans with regard to the prescribed dose levels and the dose to the organs at risk (OARs).ConclusionMRL can be used to select patients with limited lymph node involvement for pelvic radiotherapy. MRL-guided delineation of a boost volume and an elective pelvic target volume for selective high-dose lymph node irradiation with IMRT is feasible. Whether this approach will result in improved outcome for these patients needs to be investigated in further clinical studies. To demonstrate the feasibility of magnetic resonance lymphography (MRL) –guided delineation of a boost volume and an elective target volume for pelvic lymph node irradiation in patients with prostate cancer. The feasibility of irradiating these volumes with a high-dose boost to the MRL-positive lymph nodes in conjunction with irradiation of the prostate using intensity-modulated radiotherapy (IMRT) was also investigated. In 4 prostate cancer patients with a high risk of lymph node involvement but no enlarged lymph nodes on CT and/or MRI, MRL detected pathological lymph nodes in the pelvis. These lymph nodes were identified and delineated on a radiotherapy planning CT to create a boost volume. Based on the location of the MRL-positive lymph nodes, the standard elective pelvic target volume was individualized. An IMRT plan with a simultaneous integrated boost (SIB) was created with dose prescriptions of 42 Gy to the pelvic target volume, a boost to 60 Gy to the MRL-positive lymph nodes, and 72 Gy to the prostate. All MRL-positive lymph nodes could be identified on the planning CT. This information could be used to delineate a boost volume and to individualize the pelvic target volume for elective irradiation. IMRT planning delivered highly acceptable radiotherapy plans with regard to the prescribed dose levels and the dose to the organs at risk (OARs). MRL can be used to select patients with limited lymph node involvement for pelvic radiotherapy. MRL-guided delineation of a boost volume and an elective pelvic target volume for selective high-dose lymph node irradiation with IMRT is feasible. Whether this approach will result in improved outcome for these patients needs to be investigated in further clinical studies." @default.
- W2140404153 created "2016-06-24" @default.
- W2140404153 creator A5010049892 @default.
- W2140404153 creator A5012052834 @default.
- W2140404153 creator A5023267199 @default.
- W2140404153 creator A5024003056 @default.
- W2140404153 creator A5030962499 @default.
- W2140404153 creator A5037442794 @default.
- W2140404153 creator A5050756461 @default.
- W2140404153 creator A5058632107 @default.
- W2140404153 creator A5072142343 @default.
- W2140404153 date "2012-01-01" @default.
- W2140404153 modified "2023-09-26" @default.
- W2140404153 title "Magnetic Resonance Lymphography–Guided Selective High-Dose Lymph Node Irradiation in Prostate Cancer" @default.
- W2140404153 cites W1608828849 @default.
- W2140404153 cites W1965408806 @default.
- W2140404153 cites W1975388728 @default.
- W2140404153 cites W1983479897 @default.
- W2140404153 cites W2004423705 @default.
- W2140404153 cites W2004601306 @default.
- W2140404153 cites W2010751529 @default.
- W2140404153 cites W2013749950 @default.
- W2140404153 cites W2017464827 @default.
- W2140404153 cites W2021220421 @default.
- W2140404153 cites W2025813238 @default.
- W2140404153 cites W2033839987 @default.
- W2140404153 cites W2042152896 @default.
- W2140404153 cites W2056643793 @default.
- W2140404153 cites W2063266750 @default.
- W2140404153 cites W2076496215 @default.
- W2140404153 cites W2088042522 @default.
- W2140404153 cites W2088525015 @default.
- W2140404153 cites W2097532477 @default.
- W2140404153 cites W2111784792 @default.
- W2140404153 cites W2116810900 @default.
- W2140404153 cites W2118792538 @default.
- W2140404153 cites W2124586180 @default.
- W2140404153 cites W2137571400 @default.
- W2140404153 cites W2156537036 @default.
- W2140404153 cites W2160679358 @default.
- W2140404153 cites W2163915308 @default.
- W2140404153 cites W2167949509 @default.
- W2140404153 doi "https://doi.org/10.1016/j.ijrobp.2010.09.023" @default.
- W2140404153 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21075555" @default.
- W2140404153 hasPublicationYear "2012" @default.
- W2140404153 type Work @default.
- W2140404153 sameAs 2140404153 @default.
- W2140404153 citedByCount "20" @default.
- W2140404153 countsByYear W21404041532012 @default.
- W2140404153 countsByYear W21404041532013 @default.
- W2140404153 countsByYear W21404041532014 @default.
- W2140404153 countsByYear W21404041532015 @default.
- W2140404153 countsByYear W21404041532016 @default.
- W2140404153 countsByYear W21404041532017 @default.
- W2140404153 countsByYear W21404041532019 @default.
- W2140404153 crossrefType "journal-article" @default.
- W2140404153 hasAuthorship W2140404153A5010049892 @default.
- W2140404153 hasAuthorship W2140404153A5012052834 @default.
- W2140404153 hasAuthorship W2140404153A5023267199 @default.
- W2140404153 hasAuthorship W2140404153A5024003056 @default.
- W2140404153 hasAuthorship W2140404153A5030962499 @default.
- W2140404153 hasAuthorship W2140404153A5037442794 @default.
- W2140404153 hasAuthorship W2140404153A5050756461 @default.
- W2140404153 hasAuthorship W2140404153A5058632107 @default.
- W2140404153 hasAuthorship W2140404153A5072142343 @default.
- W2140404153 hasConcept C121608353 @default.
- W2140404153 hasConcept C126322002 @default.
- W2140404153 hasConcept C126838900 @default.
- W2140404153 hasConcept C142724271 @default.
- W2140404153 hasConcept C143409427 @default.
- W2140404153 hasConcept C201645570 @default.
- W2140404153 hasConcept C2776235491 @default.
- W2140404153 hasConcept C2778357063 @default.
- W2140404153 hasConcept C2779720271 @default.
- W2140404153 hasConcept C2780192828 @default.
- W2140404153 hasConcept C2780849966 @default.
- W2140404153 hasConcept C2989005 @default.
- W2140404153 hasConcept C509974204 @default.
- W2140404153 hasConcept C71924100 @default.
- W2140404153 hasConceptScore W2140404153C121608353 @default.
- W2140404153 hasConceptScore W2140404153C126322002 @default.
- W2140404153 hasConceptScore W2140404153C126838900 @default.
- W2140404153 hasConceptScore W2140404153C142724271 @default.
- W2140404153 hasConceptScore W2140404153C143409427 @default.
- W2140404153 hasConceptScore W2140404153C201645570 @default.
- W2140404153 hasConceptScore W2140404153C2776235491 @default.
- W2140404153 hasConceptScore W2140404153C2778357063 @default.
- W2140404153 hasConceptScore W2140404153C2779720271 @default.
- W2140404153 hasConceptScore W2140404153C2780192828 @default.
- W2140404153 hasConceptScore W2140404153C2780849966 @default.
- W2140404153 hasConceptScore W2140404153C2989005 @default.
- W2140404153 hasConceptScore W2140404153C509974204 @default.
- W2140404153 hasConceptScore W2140404153C71924100 @default.
- W2140404153 hasIssue "1" @default.
- W2140404153 hasLocation W21404041531 @default.
- W2140404153 hasLocation W21404041532 @default.
- W2140404153 hasOpenAccess W2140404153 @default.
- W2140404153 hasPrimaryLocation W21404041531 @default.